Syndax Pharmaceuticals (SNDX) Net Cash Flow Growth (3y) (2018 - 2026)
Syndax Pharmaceuticals (SNDX) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-13.44% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
37.88% |
| Date | Value |
|---|
| Mar 31, 2026 |
37.88% |
| Dec 31, 2025 |
82.16% |
| Sep 30, 2025 |
29.41% |
| Jun 30, 2025 |
12.85% |
| Mar 31, 2025 |
86.06% |
| Dec 31, 2024 |
-48.08% |
| Sep 30, 2024 |
101.19% |
| Jun 30, 2024 |
-65.37% |
| Mar 31, 2024 |
-52.62% |
| Dec 31, 2023 |
50.53% |
| Sep 30, 2023 |
-44.11% |
| Jun 30, 2023 |
64.33% |
| Mar 31, 2023 |
-41.63% |
| Dec 31, 2022 |
35.55% |
| Sep 30, 2022 |
-143.74% |
| Jun 30, 2022 |
-29.65% |
| Mar 31, 2022 |
-49.83% |
| Dec 31, 2021 |
177.24% |
| Sep 30, 2021 |
37.80% |
| Jun 30, 2021 |
-4.71% |
